U.S. Department of Health & Human Services
Open Funding Opportunities
| FOA # | FOA Title | Research Focus Area | Earliest Submission Date | Expiration Date | Posted Date Sort ascending |
|---|---|---|---|---|---|
| OTA-22-005 (PDF, 459 kb) Show Summary |
HEAL Research-Dissemination and Engagement Center (R-DEC) | Cross-Cutting Research | Mon, 06/13/2022 | Mon, 07/18/2022 | Wed, 05/18/2022 |
|
The purpose of this announcement is to invite applications to implement and support activities in the role of the HEAL Research Dissemination and Engagement Center (R-DEC). This Center will generate, manage, and coordinate processes and products that connect the growing evidence base of HEAL research with communities, organizations, government entities, and other potential beneficiaries of HEAL research results. Applications should include proposals for the initial planning phase of the HEAL dissemination and community engagement program to define and develop culturally appropriate, inclusive ways to communicate with the beneficiaries of HEAL research. |
|||||
| RFA-NS-22-060 | Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed) | Clinical Research in Pain Management | Wed, 06/15/2022 | Sat, 07/16/2022 | Thu, 05/05/2022 |
|
no summary
|
|||||
| RFA-NS-22-052 | HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Mon, 05/09/2022 | Wed, 10/11/2023 | Fri, 04/22/2022 |
|
no summary
|
|||||
| NOT-NS-22-049 | Notice of Early Termination of RFA-NS-21-015 "HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed)" | Preclinical and Translational Research in Pain Management | Sat, 03/27/2021 | Wed, 10/11/2023 | Fri, 04/22/2022 |
|
no summary
|
|||||
| NOT-OD-22-110 | Notice of Special Interest (NOSI): Availability of Administrative Supplements for Helping to End Addiction Long-term (HEAL) Initiative awardees to make data Findable, Accessible, Interoperable, and Reusable (FAIR) through the HEAL Data Ecosystem | Cross-Cutting Research | Tue, 05/31/2022 | Wed, 06/01/2022 | Fri, 04/22/2022 |
|
no summary
|
|||||
| NOT-NS-22-094 | Notice of Intent to Publish a Funding Opportunity Announcement for Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed) | Clinical Research in Pain Management | Fri, 07/15/2022 | Sat, 07/23/2022 | Wed, 04/13/2022 |
|
no summary
|
|||||
| NOT-DA-22-056 | Notice of Special Interest (NOSI): Developing Digital Therapeutics for Substance Use Disorders | Novel Medication Options for Opioid Use Disorder and Overdose | Wed, 04/06/2022 | Thu, 12/07/2023 | Fri, 02/18/2022 |
|
no summary
|
|||||
| RFA-NS-22-050 | HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) | Preclinical and Translational Research in Pain Management | Fri, 02/11/2022 | Fri, 02/24/2023 | Tue, 02/08/2022 |
|
no summary
|
|||||
| NOT-DA-22-001 | Notice of Change to Key Dates for NIDA PAR-21-183, Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) | Novel Medication Options for Opioid Use Disorder and Overdose | Sun, 07/04/2021 | Thu, 12/07/2023 | Sun, 02/06/2022 |
|
no summary
|
|||||
| RFA-NS-22-018 | HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Thu, 02/17/2022 | Fri, 03/10/2023 | Fri, 02/04/2022 |
|
no summary
|
|||||
| RFA-NS-22-021 | HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Thu, 02/17/2022 | Wed, 10/12/2022 | Tue, 02/01/2022 |
|
no summary
|
|||||
| PAR-22-058 | Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) | Preclinical and Translational Research in Pain Management | Tue, 02/15/2022 | Tue, 05/02/2023 | Fri, 01/21/2022 |
|
no summary
|
|||||
| RFA-TR-22-013 | Emergency Awards: HEAL Initiative – New Innovator Award (DP2 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Fri, 01/28/2022 | Tue, 05/23/2023 | Thu, 01/20/2022 |
|
no summary
|
|||||
| RFA-TR-22-011 | Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Fri, 01/28/2022 | Tue, 05/23/2023 | Thu, 01/20/2022 |
|
no summary
|
|||||
| NOT-TR-22-015 | Notice of Early Termination of PAR-22-057 "Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)" | Cross-Cutting Research | Tue, 02/15/2022 | Tue, 05/02/2023 | Thu, 01/20/2022 |
|
no summary
|
|||||
| RFA-NS-22-034 | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Wed, 02/02/2022 | Sat, 12/07/2024 | Fri, 01/07/2022 |
|
no summary
|
|||||
| NOT-DA-22-049 | Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders | Preclinical and Translational Research in Pain Management | Sat, 01/01/2022 | Fri, 09/02/2022 | Wed, 12/22/2021 |
|
no summary
|
|||||
| OTA-22-002 (PDF, 281K) | EPICC-Net Pain Research Asset Application (OT2) [ROLLING SUBMISSION ACCEPTED: DATES ARE ESTIMATED] | Clinical Research in Pain Management | Fri, 12/17/2021 | Sat, 12/31/2022 | Fri, 12/17/2021 |
|
no summary
|
|||||
| RFA-NS-21-029 | HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sat, 06/19/2021 | Wed, 10/11/2023 | Tue, 06/08/2021 |
|
no summary
|
|||||
| NOT-NS-21-061 | Notice of Early Termination of RFA-NS-21-016, HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sat, 06/19/2021 | Wed, 10/11/2023 | Tue, 05/18/2021 |
|
no summary
|
|||||
| PAR-21-183 | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) | Novel Medication Options for Opioid Use Disorder and Overdose | Sun, 07/04/2021 | Thu, 12/07/2023 | Tue, 03/23/2021 |
|
no summary
|
|||||
| OTA-21-005 | HEAL Initiative: EPPIC-Net Pain Research Asset Application (OT1) | Clinical Research in Pain Management | Fri, 12/17/2021 | Tue, 09/03/2024 | Thu, 02/25/2021 |
|
no summary
|
|||||
| NOT-NS-20-107 Show Summary |
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | Cross-Cutting Research | Sun, 11/15/2020 | Thu, 05/16/2024 | Mon, 10/19/2020 |
|
Diversity Supplement Guidance pdf 221.15 KB |
|||||
| RFA-NS-21-010 | HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) | Preclinical and Translational Research in Pain Management | Sun, 10/18/2020 | Thu, 09/08/2022 | Wed, 09/16/2020 |
|
no summary
|
|||||
| PAR-20-092 | Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) | Novel Medication Options for Opioid Use Disorder and Overdose | Fri, 01/24/2020 | Fri, 09/02/2022 | Fri, 01/24/2020 |
|
no summary
|
|||||
| RFA-NS-20-008 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-011 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-010 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-009 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Thu, 10/03/2019 |
|
no summary
|
|||||